Glomerular Disease Education Experience across Nephrology Fellowship Programs: An International Survey

Autor: Harish Seethapathy, Sayna Norouzi, Kate J. Robson, Lida Gharibvand, Ali Poyan Mehr

Publikováno v: Glomerular Diseases (2021)

Introduction: Glomerular disease (GN) education is an important, albeit a challenging component of nephrology fellowship training. We hypothesized that trainee experience varies widely across programs, leading to differences in self-reported comfort

Externí odkaz: https://doaj.org/article/c655ca8bd9e741a5a5a595301448ea18

The Glomerular Disease Study and Trial Consortium: A Grassroots Initiative to Foster Collaboration and Innovation

Autor: Ali Poyan Mehr, Maryam Sadeghi-Najafabadi, Kristi Chau, Joseph Messmer, Rima Pai, Neil Roy, David Friedman, Martin R. Pollak, Johannes Schlondorff, Mihran Naljayan, Tripti Singh, Stewart H. Lecker, Roger Rodby, Michael Germain, Helmut Rennke, Isaac E. Stillman

Publikováno v: Kidney International Reports, Vol 4, Iss 1, Pp 20-29 (2019)

Glomerular kidney disorders account for a significant proportion of chronic kidney disease and end-stage renal disease worldwide. Nevertheless, major obstacles make breakthrough progress in diagnosis and cure an ongoing challenge. Here we report the

Externí odkaz: https://doaj.org/article/e12b0fcdabab47a6b630f384c2e71b50

The Implementation of a Virtual Home Dialysis Mentoring Program for Nephrologists

Autor: Ali Poyan Mehr, Christopher Chan, Brigitte Schiller, Graham Abra

Publikováno v: Kidney360

Virtual home dialysis physician mentorship is feasible. In total, 53% of participants perceived the program would change the perspective of participants on prescribing home dialysis. More research is needed to ascertain the effect of virtual mentorsh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cadcd93cc8e4fbe04a88a520330bccad
https://doi.org/10.34067/kid.0000202022

The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction

Autor: Megan K. Yee, John Feaster, Majdi Halabi, John J.P. Kastelein, Serge Korjian, Dominick J. Angiolillo, Ravindra L. Mehta, Mathieu Kerneis, Béla Merkely, Danielle Duffy, C. Michael Gibson, Daniel Duerschmied, Ton Oude Ophuis, Basil S. Lewis, Pierluigi Tricoci, Yazan Daaboul, Ali Poyan Mehr, Roxana Mehran, John H. Alexander, Christoph Bode

Publikováno v: American Heart Journal
American Heart Journal, Elsevier, 2019, 208, pp.81-90. ⟨10.1016/j.ahj.2018.11.008⟩
American heart journal, 208, 81-90. Mosby Inc.

International audience; BACKGROUND:CSL112 (apolipoprotein A-I [human]) is a plasma-derived apolipoprotein A-I developed for early reduction of cardiovascular risk following an acute myocardial infarction (AMI). The safety of CSL112 among AMI subjects

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0a74aa74f7ff3e8fb22625c99672494
https://doi.org/10.1016/j.ahj.2018.11.008

Niacinamide May Be Associated with Improved Outcomes in COVID-19-Related Acute Kidney Injury: An Observational Study

Autor: Kenneth J. Mukamal, Samir M. Parikh, Ali Poyan Mehr, Nathan Raines, Pitchaphon Nissaisorakarn, Theodore I. Steinman, Alexander Morales, Rahul Maheshwari, Vigyan Bang, Sourbha S. Dani, Mehrnaz Sadrolashrafi, Aarti Asnani, Amitoj Singh, Katherine Shreyder, Robert S. Brown, Johannes Schlondorff, Sarju Ganatra, Amar Pandit, Mark L. Zeidel, Rushin Patel, Sarah Knapp, Simarjeet Brar, Rhea Bhargava

Publikováno v: Kidney360

BACKGROUND: AKI is a significant complication of coronavirus disease 2019 (COVID-19), with no effective therapy. Niacinamide, a vitamin B3 analogue, has some evidence of efficacy in non-COVID-19-related AKI. The objective of this study is to evaluate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fa92ce349f4028b35e9ee94b926372e
https://europepmc.org/articles/PMC8785722/